To ask the Secretary of State for Health and Social Care, what plans his Department has to order Evusheld for use in the NHS.
Answered on
8 June 2022
The Department continues to examine the potential introduction of prophylaxis, which includes deployment and administration processes. On 17 March 2022, Evusheld was granted conditional marketing approval by the Medicines and Healthcare products Regulatory Agency. However, the approval highlighted uncertainty over the dose required for protection against the Omicron variants.
We have asked clinicians to advise on the most appropriate option for the National Health Service in line with all available data, the public health situation and other treatments available.
Answered by
Department of Health and Social Care